Skip to main content
Erschienen in: Neurosurgical Review 2/2019

02.05.2018 | Original Article

Characteristic features and proposed classification in 69 cases of intracranial microcystic meningiomas

verfasst von: Zhiqin Lin, Meng Zhao, Xiangrong Li, Junmei Wang, Ping Qiu, Folin Lan, Celin Guan, Dongxia Liao, Dongwei Shen, Jing Lu, Shuanglin Que, Zhongli Jiang

Erschienen in: Neurosurgical Review | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Microcystic meningioma (MM) is a rare subtype of intracranial meningiomas, with clinical and radiologic features not well characterized in the literature. Based on our experience, we propose a classification system of intracranial MMs. We reviewed the medical records, radiographic studies, and operative notes of a group of consecutive patients with intracranial MM. The mean age of the 69 patients was 46.8 ± 10.6 years (range, 21–75 years). Three types of intracranial MMs could be identified. Type 1 MMs presented as a solid lesion, hypointense or isointense on T1WI, hyperintense on T2WI, and homogeneous or heterogeneous enhancement, and were found in 43 patients (67.2%). Type 2 MMs represented signals similar to CSF both on T1WI and T2WI, and faint reticular enhancement with marginal enhancement, and these were found in 7 patients (10.9%). Type 3 MMs consisted of cystic-solid or cystic lesion and were found in 14 patients (21.9%). Significant differences were observed among the different types of MMs for the following variables: sex, presence of severe peritumoral brain edema (PTBE), and extent of tumor resection. Females were found in all of patients with type 2 MMs, but were only 35.7% of those with type 3 MMs (P = 0.018). Severe PTBEs were more common among patients with type 1 MMs (55.8%) than among those with type 2 (14.3%) and type 3 MMs (14.3%) (P = 0.007). Type 1 MMs (97.7%) were associated with a significantly higher rate of gross total resection compared with the other two types (71.4 and 78.6%) (P = 0.019). Total length of hospital stay after craniotomy ranged from 4 to 30 days (median, 8 days). There were no significant differences in progression-free survival among the three types of MMs (P = 0.788). The current classification identifies three distinct types of intracranial MM based on their radiological findings and growth patterns. The type 1 MMs are more commonly associated with severe PTBE. Type 2 and Type 3 MMs have a higher predilection towards parasaggital location with venous involvement and therefore have a lower rate of gross total resection.
Literatur
1.
Zurück zum Zitat Boukobza M, Cebula H, Pop R, Kouakou F, Sadoun A, Coca HA, Polivka M, Diemidio P, Ganau M, George B, Froelich S, Proust F, Chibbaro S (2016) Cystic meningioma: radiological, histological, and surgical particularities in 43 patients. Acta Neurochir 158:1955–1964CrossRefPubMed Boukobza M, Cebula H, Pop R, Kouakou F, Sadoun A, Coca HA, Polivka M, Diemidio P, Ganau M, George B, Froelich S, Proust F, Chibbaro S (2016) Cystic meningioma: radiological, histological, and surgical particularities in 43 patients. Acta Neurochir 158:1955–1964CrossRefPubMed
2.
Zurück zum Zitat Buetow MP, Buetow PC, Smirniotopoulos JG (1991) Typical, atypical, and misleading features in meningioma. Radiographics 11:1087–1106CrossRefPubMed Buetow MP, Buetow PC, Smirniotopoulos JG (1991) Typical, atypical, and misleading features in meningioma. Radiographics 11:1087–1106CrossRefPubMed
3.
Zurück zum Zitat Burger PC (1995) Revising the World Health Organization (WHO) blue book—‘Histological typing of tumours of the central nervous system’. J Neuro-Oncol 24:3–7CrossRef Burger PC (1995) Revising the World Health Organization (WHO) blue book—‘Histological typing of tumours of the central nervous system’. J Neuro-Oncol 24:3–7CrossRef
4.
Zurück zum Zitat Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223:11–29CrossRefPubMed Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223:11–29CrossRefPubMed
5.
Zurück zum Zitat Chen CJ, Tseng YC, Hsu HL, Jung SM (2008) Microcystic meningioma: importance of obvious hypointensity on T1-weighted magnetic resonance images. J Comput Assist Tomogr 32:130–134CrossRefPubMed Chen CJ, Tseng YC, Hsu HL, Jung SM (2008) Microcystic meningioma: importance of obvious hypointensity on T1-weighted magnetic resonance images. J Comput Assist Tomogr 32:130–134CrossRefPubMed
6.
Zurück zum Zitat Christov C, Lechapt-Zalcman E, Adle-Biassette H, Nachev S, Gherardi RK (1999) Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor flt-1 in microcystic meningiomas. Acta Neuropathol 98:414–420CrossRefPubMed Christov C, Lechapt-Zalcman E, Adle-Biassette H, Nachev S, Gherardi RK (1999) Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor flt-1 in microcystic meningiomas. Acta Neuropathol 98:414–420CrossRefPubMed
7.
Zurück zum Zitat Danisman MC, Kelesoglu KS, Sivri M, Koplay M, Paksoy Y (2017) Microcystic meningioma: difficulties in diagnosis and magnetic resonance imaging findings. Acta Neurol Belg 117:745–747CrossRefPubMed Danisman MC, Kelesoglu KS, Sivri M, Koplay M, Paksoy Y (2017) Microcystic meningioma: difficulties in diagnosis and magnetic resonance imaging findings. Acta Neurol Belg 117:745–747CrossRefPubMed
8.
Zurück zum Zitat Goldman CK, Bharara S, Palmer CA, Vitek J, Tsai JC, Weiss HL, Gillespie GY (1997) Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. Neurosurgery 40:1269–1277CrossRefPubMed Goldman CK, Bharara S, Palmer CA, Vitek J, Tsai JC, Weiss HL, Gillespie GY (1997) Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. Neurosurgery 40:1269–1277CrossRefPubMed
9.
Zurück zum Zitat Hakyemez B, Yildirim N, Erdoğan C, Kocaeli H, Korfali E, Parlak M (2006) Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation? Neuroradiology 48:695–702CrossRefPubMed Hakyemez B, Yildirim N, Erdoğan C, Kocaeli H, Korfali E, Parlak M (2006) Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation? Neuroradiology 48:695–702CrossRefPubMed
10.
Zurück zum Zitat Kalani MY, Cavallo C, Coons SW, Lettieri SC, Nakaji P, Porter RW, Spetzler RF, Feiz-Erfan I (2015) Long-term follow-up of surgical resection of microcystic meningiomas. J Clin Neurosci 22:713–717CrossRefPubMed Kalani MY, Cavallo C, Coons SW, Lettieri SC, Nakaji P, Porter RW, Spetzler RF, Feiz-Erfan I (2015) Long-term follow-up of surgical resection of microcystic meningiomas. J Clin Neurosci 22:713–717CrossRefPubMed
11.
Zurück zum Zitat Kalkanis SN, Carroll RS, Zhang J, Zamani AA, Black PM (1996) Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. J Neurosurg 85:1095–1101CrossRefPubMed Kalkanis SN, Carroll RS, Zhang J, Zamani AA, Black PM (1996) Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. J Neurosurg 85:1095–1101CrossRefPubMed
12.
Zurück zum Zitat Kim SH, Kim DG, Kim CY, Choc G, Chang KH, Jung HW (2003) Microcystic meningioma: the characteristic neuroradiologic findings. J Korean Neurosurg S 35:401–406 Kim SH, Kim DG, Kim CY, Choc G, Chang KH, Jung HW (2003) Microcystic meningioma: the characteristic neuroradiologic findings. J Korean Neurosurg S 35:401–406
13.
Zurück zum Zitat Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3:255–268CrossRefPubMed Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3:255–268CrossRefPubMed
14.
Zurück zum Zitat Kubota Y, Ueda T, Kagawa Y, Sakai N, Hara A (1997) Microcystic meningioma without enhancement on neuroimaging: case report. Neurol Med Chir (Tokyo) 37:407–410CrossRef Kubota Y, Ueda T, Kagawa Y, Sakai N, Hara A (1997) Microcystic meningioma without enhancement on neuroimaging: case report. Neurol Med Chir (Tokyo) 37:407–410CrossRef
15.
Zurück zum Zitat Kuchna I, Matyja E, Wierzba-Bobrowicz T, Mazurowski W (1994) Microcystic meningioma—a rarely occurring morphological variant of meningioma. Folia Neuropathol 32:259–263PubMed Kuchna I, Matyja E, Wierzba-Bobrowicz T, Mazurowski W (1994) Microcystic meningioma—a rarely occurring morphological variant of meningioma. Folia Neuropathol 32:259–263PubMed
16.
Zurück zum Zitat Kunimatsu A, Kunimatsu N, Kamiya K, Katsura M, Mori H, Ohtomo K (2016) Variants of meningiomas: a review of imaging findings and clinical features. Jpn J Radiol 34:459–469CrossRefPubMed Kunimatsu A, Kunimatsu N, Kamiya K, Katsura M, Mori H, Ohtomo K (2016) Variants of meningiomas: a review of imaging findings and clinical features. Jpn J Radiol 34:459–469CrossRefPubMed
17.
Zurück zum Zitat Lin Z, Zhao M, Ren X, Wang J, Li Z, Chen X, Wang Y, Li X, Wang C, Jiang Z (2017) Clinical features, radiologic findings, and surgical outcomes of 65 intracranial psammomatous meningiomas. World Neurosurg 100:395–406CrossRefPubMed Lin Z, Zhao M, Ren X, Wang J, Li Z, Chen X, Wang Y, Li X, Wang C, Jiang Z (2017) Clinical features, radiologic findings, and surgical outcomes of 65 intracranial psammomatous meningiomas. World Neurosurg 100:395–406CrossRefPubMed
18.
Zurück zum Zitat Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820CrossRefPubMed Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820CrossRefPubMed
19.
Zurück zum Zitat Matsushima N, Maeda M, Takamura M, Matsubara T, Taki W, Takeda K (2007) MRI findings of atypical meningioma with microcystic changes. J Neuro-Oncol 82:319–321CrossRef Matsushima N, Maeda M, Takamura M, Matsubara T, Taki W, Takeda K (2007) MRI findings of atypical meningioma with microcystic changes. J Neuro-Oncol 82:319–321CrossRef
20.
Zurück zum Zitat Michaud J, Gagne F (1983) Microcystic meningioma. Clinicopathologic report of eight cases. Arch Pathol Lab Med 107:75–80PubMed Michaud J, Gagne F (1983) Microcystic meningioma. Clinicopathologic report of eight cases. Arch Pathol Lab Med 107:75–80PubMed
21.
Zurück zum Zitat Nishio S, Takeshita I, Morioka T, Fukui M (1994) Microcystic meningiomas: clinicopathological features of 6 cases. Neurol Res 16:251–256CrossRefPubMed Nishio S, Takeshita I, Morioka T, Fukui M (1994) Microcystic meningiomas: clinicopathological features of 6 cases. Neurol Res 16:251–256CrossRefPubMed
22.
Zurück zum Zitat Osawa T, Tosaka M, Nagaishi M, Yoshimoto Y (2013) Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema. J Neuro-Oncol 111:49–57CrossRef Osawa T, Tosaka M, Nagaishi M, Yoshimoto Y (2013) Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema. J Neuro-Oncol 111:49–57CrossRef
23.
Zurück zum Zitat Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JS (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro-Oncology 15(suppl 2):ii1–ii56CrossRefPubMedPubMedCentral Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JS (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro-Oncology 15(suppl 2):ii1–ii56CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Paek SH, Kim CY, Kim YY, Park IA, Kim MS, Kim DG, Jung HW (2002) Correlation of clinical and biological parameters with peritumoral edema in meningioma. J Neuro-Oncol 60:235–245CrossRef Paek SH, Kim CY, Kim YY, Park IA, Kim MS, Kim DG, Jung HW (2002) Correlation of clinical and biological parameters with peritumoral edema in meningioma. J Neuro-Oncol 60:235–245CrossRef
25.
Zurück zum Zitat Paek SH, Kim SH, Chang KH, Park CK, Kim JE, Kim DG, Park SH, Jung HW (2005) Microcystic meningiomas: radiological characteristics of 16 cases. Acta Neurochir 147:965–972CrossRefPubMed Paek SH, Kim SH, Chang KH, Park CK, Kim JE, Kim DG, Park SH, Jung HW (2005) Microcystic meningiomas: radiological characteristics of 16 cases. Acta Neurochir 147:965–972CrossRefPubMed
26.
Zurück zum Zitat Provias J, Claffey K, delAguila L, Lau N, Feldkamp M, Guha A (1997) Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 40:1016–1026CrossRefPubMed Provias J, Claffey K, delAguila L, Lau N, Feldkamp M, Guha A (1997) Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 40:1016–1026CrossRefPubMed
27.
Zurück zum Zitat Raza SM, Gallia GL, Brem H, Weingart JD, Long DM, Olivi A (2010) Perioperative and long-term outcomes from the management of parasagittal meningiomas invading the superior sagittal sinus. Neurosurgery 67:885–893CrossRefPubMed Raza SM, Gallia GL, Brem H, Weingart JD, Long DM, Olivi A (2010) Perioperative and long-term outcomes from the management of parasagittal meningiomas invading the superior sagittal sinus. Neurosurgery 67:885–893CrossRefPubMed
28.
Zurück zum Zitat Rishi A, Black KS, Woldenberg RW, Overby CM, Eisenberg MB, Li JY (2011) Microcystic meningioma presenting as a cystic lesion with an enhancing mural nodule in elderly women: report of three cases. Brain Tumor Pathol 28:335–339CrossRefPubMed Rishi A, Black KS, Woldenberg RW, Overby CM, Eisenberg MB, Li JY (2011) Microcystic meningioma presenting as a cystic lesion with an enhancing mural nodule in elderly women: report of three cases. Brain Tumor Pathol 28:335–339CrossRefPubMed
29.
Zurück zum Zitat Roser F, Nakamura M, Ritz R, Bellinzona M, Dietz K, Samii M, Tatagiba MS (2005) Proliferation and progesterone receptor status in benign meningiomas are not age dependent. Cancer 104:598–601CrossRefPubMed Roser F, Nakamura M, Ritz R, Bellinzona M, Dietz K, Samii M, Tatagiba MS (2005) Proliferation and progesterone receptor status in benign meningiomas are not age dependent. Cancer 104:598–601CrossRefPubMed
30.
Zurück zum Zitat Sawada K, Tamaki M, Hashimoto H, Karakama J, Sato Y, Hara M, Tone O (2016) A case of microcystic meningioma with a difficult preoperative diagnosis. Jpn J Neurosurg (Tokyo) 25:62–68CrossRef Sawada K, Tamaki M, Hashimoto H, Karakama J, Sato Y, Hara M, Tone O (2016) A case of microcystic meningioma with a difficult preoperative diagnosis. Jpn J Neurosurg (Tokyo) 25:62–68CrossRef
31.
Zurück zum Zitat Schober R, Himuro H, Wechsler W (1988) Cystic changes and vascular permeability in meningiomas. Clin Neuropathol 7:16–21PubMed Schober R, Himuro H, Wechsler W (1988) Cystic changes and vascular permeability in meningiomas. Clin Neuropathol 7:16–21PubMed
32.
Zurück zum Zitat Shimoji K, Yasuma Y, Mori K, Eguchi M, Maeda M (1999) Unique radiological appearance of a microcystic meningioma. Acta Neurochir 141:1119–1121CrossRefPubMed Shimoji K, Yasuma Y, Mori K, Eguchi M, Maeda M (1999) Unique radiological appearance of a microcystic meningioma. Acta Neurochir 141:1119–1121CrossRefPubMed
34.
Zurück zum Zitat Sitthinamsuwan B, Khampalikit I, Nunta-aree S, Srirabheebhat P, Witthiwej T, Nitising A (2012) Predictors of meningioma consistency: a study in 243 consecutive cases. Acta Neurochir 154:1383–1389CrossRefPubMed Sitthinamsuwan B, Khampalikit I, Nunta-aree S, Srirabheebhat P, Witthiwej T, Nitising A (2012) Predictors of meningioma consistency: a study in 243 consecutive cases. Acta Neurochir 154:1383–1389CrossRefPubMed
35.
Zurück zum Zitat Tamiya T, Ono Y, Matsumoto K, Ohmoto T (2001) Peritumoral brain edema in intracranial meningiomas: effects of radiological and histological factors. Neurosurgery 49:1046–1051PubMed Tamiya T, Ono Y, Matsumoto K, Ohmoto T (2001) Peritumoral brain edema in intracranial meningiomas: effects of radiological and histological factors. Neurosurgery 49:1046–1051PubMed
36.
Zurück zum Zitat Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, Niessen WJ, Breteler MM, van der Lugt A (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357:1821–1828CrossRefPubMed Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, Niessen WJ, Breteler MM, van der Lugt A (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357:1821–1828CrossRefPubMed
37.
Zurück zum Zitat Vignes JR, Sesay M, Rezajooi K, Gimbert E, Liguoro D (2008) Peritumoral edema and prognosis in intracranial meningioma surgery. J Clin Neurosci 15:764–768CrossRefPubMed Vignes JR, Sesay M, Rezajooi K, Gimbert E, Liguoro D (2008) Peritumoral edema and prognosis in intracranial meningioma surgery. J Clin Neurosci 15:764–768CrossRefPubMed
38.
Zurück zum Zitat Watts J, Box G, Galvin A, Brotchie P, Trost N, Sutherland T (2014) Magnetic resonance imaging of meningiomas: a pictorial review. Insights Imaging 5:113–122CrossRefPubMedPubMedCentral Watts J, Box G, Galvin A, Brotchie P, Trost N, Sutherland T (2014) Magnetic resonance imaging of meningiomas: a pictorial review. Insights Imaging 5:113–122CrossRefPubMedPubMedCentral
Metadaten
Titel
Characteristic features and proposed classification in 69 cases of intracranial microcystic meningiomas
verfasst von
Zhiqin Lin
Meng Zhao
Xiangrong Li
Junmei Wang
Ping Qiu
Folin Lan
Celin Guan
Dongxia Liao
Dongwei Shen
Jing Lu
Shuanglin Que
Zhongli Jiang
Publikationsdatum
02.05.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Neurosurgical Review / Ausgabe 2/2019
Print ISSN: 0344-5607
Elektronische ISSN: 1437-2320
DOI
https://doi.org/10.1007/s10143-018-0982-9

Weitere Artikel der Ausgabe 2/2019

Neurosurgical Review 2/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.